Needham analyst Quinn Bolton maintains MACOM Technology Solns (NASDAQ:MTSI) with a Buy and raises the price target from $62 to $68.
Barclays Maintains Overweight on Nutrien, Lowers Price Target to $95
Barclays analyst Benjamin Theurer maintains Nutrien (NYSE:NTR) with a Overweight and lowers the price target from $105 to $95.